Whole blood used for researching the causes, diagnosis, supportive care and treatment of chronic lymphocitic leukemia (CLL). The whole blood is collected from IRB-consented donors diagnosed with CLL.
No pre screening is done on fresh products, but donors are tested on day of collection for Hepatitis B, Hepatitis C, HIV 1/2, HTLV-I/II, HIV-1/HCV/HBV Nucleic Acid, WNV Nucleic Acid, Trypanasoma cruzi and Syphilis.
Storage: Use immediately upon receipt.
Attention: Intended for research use only and not for direct therapeutic or diagnostic use in human or animals, or for further manufacturing of therapeutic products or devices.